NFKB1 and periodontitis: Emerging evidence supports the idea that periodontitis could be treated by inhibiting pro-inflammatory molecular signaling pathways such as NF-κB or poly (ADP-ribose) polymerase (PARP) activation, as demonstrated in an animal model of periodontitis [63,64].